In National Advertising Division Challenge, Neurotrack Voluntarily Discontinues Certain Cognitive Health Program Claims
New York, NY – April 4, 2023 – Following a BBB National Programs National Advertising Division (NAD) challenge, brought by competitor Posit Science, Neurotrack Technologies, Inc. voluntarily discontinued certain claims for its Cognitive Health Program, including:
- “Clinically proven” or “clinically validated” claims.
- Claims about reduction of risk of Alzheimer’s and other dementias.
- Claims relating to improvement in cognitive health and prevention of cognitive decline.
Neurotrack is a digital health company that markets a web-based screening tool and cognitive health program intended to help diagnose and manage cognitive decline attributable to aging, including dementias such as Alzheimer’s disease. The challenged claims appeared on the Neurotrack website.
The challenger, Posit Science, is a developer and marketer of brain-training exercise software and services.
During the proceeding, Neurotrack informed NAD that it was in the process of significantly modifying its website and that it had elected to voluntarily and permanently discontinue the challenged claims. Therefore, NAD did not review the claims on their merits.
In its advertiser statement, Neurotrack agreed to comply with NAD’s recommendations and stated that “for business reasons, and to avoid a protracted dispute, Neurotrack is voluntarily revising its website to ensure that its communications better align with its evidence-backed offerings.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims
McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.
Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action
McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.
Children’s Advertising Review Unit Recommends JustPlay Discontinue or Modify Daisy the Yoga Goat Claims
New York, NY – December 19, 2024 - The Children’s Advertising Review Unit (CARU) launched an investigation into advertising for Just Play’s furReal Daisy the Yoga Goat seeking to determine if the toy’s product packaging and commercial advertisements comply with CARU’s Self-Regulatory Guidelines for Children’s Advertising.
In National Advertising Division Fast-Track SWIFT Challenge, Oral Essentials Voluntarily Modifies “Made in USA” Claims
New York, NY – December 19, 2024 – In a National Advertising Division challenge, Oral Essentials agreed to permanently modify its claim that certain Oral Essentials oral healthcare products are “Made in USA.”